e-learning
resources
ERS Research Seminars
2019
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Targeting the detrimental effects of sleep disturbances in OSA: CPAP and what else?
Manuel Sanchez De La Torre (Lleida, Spain)
Source:
Research seminar - Targeting the detrimental effects of sleep disturbances and disorders – towards personalized treatment in respiratory diseases
Number:
12
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Manuel Sanchez De La Torre (Lleida, Spain). Targeting the detrimental effects of sleep disturbances in OSA: CPAP and what else?. Research seminar - Targeting the detrimental effects of sleep disturbances and disorders – towards personalized treatment in respiratory diseases
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
The impact of CPAP on neurocognitive function in sleep-disordered breathing: why are the signals so weak?
Source: International Congress 2015 – Does sleep apnoea impact cognitive function?
Year: 2015
When CPAP is stopped: what are the “on switches” of sleep apnoea?
Source: Eur Respir J 2014; 43: 1227-1229
Year: 2014
Cardiovascular consequences of sleep disordered breathing: the role of CPAP treatment
Source: Eur Respir Monogr 2020; 88: 118-142
Year: 2020
Effects of sleep apnoea therapy on blood pressure and metabolism: a CPAP sex gap?
Source: Eur Respir J, 50 (2) 1700987; 10.1183/13993003.00987-2017
Year: 2017
Is there a metabolic effect of continuous positive airway pressure in sleep apnoea? Adherence should not be underestimated
Source: Eur Respir J 2009; 34: 1209-1210
Year: 2009
The role of compliance with positive airway pressure use on blood pressure in patients with obstructive sleep apnea: Is longer use a key-factor?
Source: International Congress 2015 – Paediatric and adult sleep-disordered breathing: from inflammation to treatment and telemedicine
Year: 2015
Sleep apnoea and post-stroke vascular events: is it only due to poor continuous positive airway pressure use?
Source: Eur Respir J 2012; 40: 513
Year: 2012
Sleep apnoea and post-stroke vascular events: is it only due to poor continuous positive airway pressure use?
Source: Eur Respir J 2012; 40: 514
Year: 2012
Can CPAP reduce adverse cardiovascular and metabolic effects of OSAS?
Source: Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS)
Year: 2007
Exploring the impact of continuous positive airway pressure treatment on biological clock disruption in obstructive sleep apnea patients
Source: Sleep and Breathing Conference 2021
Year: 2021
Antioxidant status in obstructive sleep apnea: no influence of one night continuous airway pressure therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 574s
Year: 2006
Is continuous positive airway pressure necessarily an everyday therapy in patients with obstructive sleep apnoea?
Source: Eur Respir J 2014; 43: 1387-1393
Year: 2014
Glucose-Insulin metabolism in sleep apneoa patients: Effect of long term CPAP treatment
Source: Annual Congress 2003 - Systematic inflammation and metabolic disorders in sleep related breathing disorders
Year: 2003
Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients?
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006
Do beta-blockers reduce sympathetic activity in patients with mild sleep breathing disorder without CPAP therapy?
Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects
Year: 2020
Positional therapy for obstructive sleep apnea: do your patients use it at home?
Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea
Year: 2009
Who cares about mild sleep apnoea ?
Source: 5th Sleep and Breathing Conference
Year: 2019
Severe sleep apnea, type 2 diabetes and beneficial effects of CPAP on nocturnal glucose control
Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept